NO995690L - Forbindelser for diagnose av tuberkulose og metoder for deres anvendelse - Google Patents

Forbindelser for diagnose av tuberkulose og metoder for deres anvendelse

Info

Publication number
NO995690L
NO995690L NO995690A NO995690A NO995690L NO 995690 L NO995690 L NO 995690L NO 995690 A NO995690 A NO 995690A NO 995690 A NO995690 A NO 995690A NO 995690 L NO995690 L NO 995690L
Authority
NO
Norway
Prior art keywords
tuberculosis
compounds
polypeptides
methods
diagnosis
Prior art date
Application number
NO995690A
Other languages
English (en)
Norwegian (no)
Other versions
NO995690D0 (no
Inventor
Mark R Alderson
Davin C Dillon
Yasir A W Skeiky
Antonio Campos-Neto
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of NO995690D0 publication Critical patent/NO995690D0/no
Publication of NO995690L publication Critical patent/NO995690L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO995690A 1997-05-20 1999-11-19 Forbindelser for diagnose av tuberkulose og metoder for deres anvendelse NO995690L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85899897A 1997-05-20 1997-05-20
US09/073,009 US6555653B2 (en) 1997-05-20 1998-05-05 Compounds for diagnosis of tuberculosis and methods for their use
PCT/US1998/010514 WO1998053076A2 (en) 1997-05-20 1998-05-20 Compounds for diagnosis of tuberculosis and methods for their use

Publications (2)

Publication Number Publication Date
NO995690D0 NO995690D0 (no) 1999-11-19
NO995690L true NO995690L (no) 2000-01-18

Family

ID=26754013

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995690A NO995690L (no) 1997-05-20 1999-11-19 Forbindelser for diagnose av tuberkulose og metoder for deres anvendelse

Country Status (10)

Country Link
US (1) US6555653B2 (xx)
KR (1) KR20010012813A (xx)
AU (1) AU7591698A (xx)
BR (1) BR9809443A (xx)
CA (1) CA2290754A1 (xx)
IL (1) IL133055A0 (xx)
NO (1) NO995690L (xx)
PL (1) PL337333A1 (xx)
TR (1) TR200000113T2 (xx)
WO (1) WO1998053076A2 (xx)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6991797B2 (en) 1993-07-02 2006-01-31 Statens Serum Institut M. tuberculosis antigens
US6592877B1 (en) 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6458366B1 (en) 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6290969B1 (en) * 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6544522B1 (en) * 1998-12-30 2003-04-08 Corixa Corporation Fusion proteins of mycobacterium tuberculosis antigens and their uses
US6982085B2 (en) 1997-04-02 2006-01-03 Statens Serum Institut TB diagnostic based on antigens from M. tuberculosis
US7037510B2 (en) 1997-04-18 2006-05-02 Statens Serum Institut Hybrids of M. tuberculosis antigens
CA2319380A1 (en) * 1997-11-10 1999-05-20 Statens Serum Institut Nucleic acid fragments and polypeptide fragments derived from m. tuberculosis
WO2001004151A2 (en) * 1999-07-13 2001-01-18 Statens Serum Institut TUBERCULOSIS VACCINE AND DIAGNOSTICS BASED ON THE MYCOBACTERIUM TUBERCULOSIS esat-6 GENE FAMILY
US8143386B2 (en) * 1999-04-07 2012-03-27 Corixa Corporation Fusion proteins of mycobacterium tuberculosis antigens and their uses
JP5075969B2 (ja) * 1999-07-13 2012-11-21 スタテンズ セーラム インスティテュート マイコバクテリウム・ツベルクローシスｅｓａｔ−６遺伝子ファミリーベースの結核ワクチン及び診断法
WO2001009165A2 (en) * 1999-07-29 2001-02-08 The Johns Hopkins University ACTIVATION OF PEPTIDE PRODRUGS BY hK2
WO2001024820A1 (en) * 1999-10-07 2001-04-12 Corixa Corporation Fusion proteins of mycobacterium tuberculosis
US6316205B1 (en) 2000-01-28 2001-11-13 Genelabs Diagnostics Pte Ltd. Assay devices and methods of analyte detection
WO2001062893A2 (en) * 2000-02-25 2001-08-30 Corixa Corporation Compounds and methods for diagnosis and immunotherapy of tuberculosis
EP1278769A2 (en) * 2000-04-19 2003-01-29 Statens Serum Institut Tuberculosis antigens and methods of use thereof
ATE442866T1 (de) * 2000-06-20 2009-10-15 Corixa Corp Fusionsproteine aus mycobakterium tuberculosis
WO2003000721A2 (en) 2001-06-22 2003-01-03 Health Protection Agency Mycobacterial antigens expressed under low oxygen tension
WO2003004520A2 (en) 2001-07-04 2003-01-16 Health Protection Agency Mycobacterial antigens expressed during latency
WO2003063798A2 (en) * 2002-02-01 2003-08-07 Cornell Research Foundation, Inc. Compositions and methods for treatment of infectious and inflammatory diseases
US20050267025A1 (en) * 2002-02-01 2005-12-01 Ho John L Compositions and methods for treatment of infectious and inflammatory diseases
US7026465B2 (en) * 2002-02-15 2006-04-11 Corixa Corporation Fusion proteins of Mycobacterium tuberculosis
US8475735B2 (en) * 2004-11-01 2013-07-02 Uma Mahesh Babu Disposable immunodiagnostic test system
CN102220357B (zh) * 2004-11-16 2013-12-25 克鲁塞尔荷兰公司 包含重组病毒载体的多价疫苗
US8475803B2 (en) 2005-04-29 2013-07-02 Fusion Antibodies Limited Assays for diagnosis of tuberculosis and uses thereof
WO2007005627A2 (en) 2005-07-01 2007-01-11 Forsyth Dental Infirmary For Children Tuberculosis antigen detection assays and vaccines
WO2007041539A1 (en) * 2005-09-30 2007-04-12 Transcutaneous Technologies, Inc. Iontophoresis apparatus and method for the diagnosis of tuberculosis
BRPI0708865A8 (pt) * 2006-03-14 2019-01-22 Univ Oregon Health & Science métodos para produzir uma resposta imune à tuberculose
EP2021018A4 (en) * 2006-05-18 2009-06-03 Daniel G Ericson Rapid detection of mycobacterial tuberculosis and resistance to antimicrobic acid
CA2662921C (en) 2006-09-26 2018-11-20 Infectious Disease Research Institute Vaccine and pharmaceutical compositions and kits and uses thereof in stimulating an immune response with a synthetic glucopyranosyl lipid adjuvant
US20090181078A1 (en) * 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
WO2010141861A1 (en) * 2009-06-05 2010-12-09 Infectious Disease Research Institute Synthetic glucopyranosyl lipid adjuvants
DK2528621T3 (da) 2010-01-27 2017-01-02 Glaxosmithkline Biologicals Sa Modificerede tuberkuloseantigener
GB201012072D0 (en) * 2010-07-19 2010-09-01 Sec Dep For Environment Food A Diagnostic reagents
SG194083A1 (en) 2011-04-08 2013-11-29 Immune Design Corp Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
US10703784B2 (en) * 2011-09-30 2020-07-07 La Jolla Institute For Allergy And Immunology Antigens and epitopes derived from Mycobacterium tuberculosis
US9404923B2 (en) * 2012-02-07 2016-08-02 Intuitive Biosciences, Inc. Mycobacterium tuberculosis specific peptides for detection of infection or immunization in non-human primates
ES2729967T3 (es) 2012-02-07 2019-11-07 Infectious Disease Res Inst Formulaciones de adyuvante mejoradas que comprenden agonistas de TLR4 y métodos para usar las mismas
WO2013173590A1 (en) 2012-05-16 2013-11-21 Immune Design Corp. Vaccines for hsv-2
EA032326B1 (ru) 2013-04-18 2019-05-31 Иммьюн Дизайн Корп. Монотерапия gla для применения в лечении рака
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
CN106163551A (zh) 2013-12-31 2016-11-23 传染性疾病研究院 单瓶疫苗制剂
RU2613320C2 (ru) * 2015-06-29 2017-03-15 Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт фтизиопульмонологии" Министерства здравоохранения Российской Федерации (ФГБУ "УНИИФ" Минздрава России) Способ прогнозирования течения туберкулеза
AU2017273650B2 (en) 2016-06-01 2022-08-18 Access To Advanced Health Institute Nanoalum particles containing a sizing agent
MX2021014363A (es) 2019-05-25 2022-02-21 Infectious Disease Res Inst Composicion y metodo para secar por pulverizacion una emulsion de vacuna adyuvante.

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689397A (en) 1985-08-12 1987-08-25 Scripps Clinic And Research Foundation Synthetic polypeptides for detecting mycobacterial infections
US4879213A (en) 1986-12-05 1989-11-07 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
US4952395A (en) 1987-02-26 1990-08-28 Scripps Clinic And Research Foundation Mycobacterial recombinants and peptides
US4976958A (en) 1987-02-26 1990-12-11 Scripps Clinic And Research Foundation Mycobacterial recombinants and peptides
US5330754A (en) 1992-06-29 1994-07-19 Archana Kapoor Membrane-associated immunogens of mycobacteria
US6338852B1 (en) * 1995-09-01 2002-01-15 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
ES2378051T3 (es) 1995-09-01 2012-04-04 Corixa Corporation Compuestos y métodos para el diagnóstico de la tubercolosis.
US6290969B1 (en) * 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
IL123506A (en) 1995-09-01 2004-12-15 Corixa Corp Polypeptide compounds and preparations for immunotherapy and diagnosis of tuberculosis
CA2249742A1 (en) * 1996-03-15 1997-09-18 Steven G. Reed Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer
US6284255B1 (en) * 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US5985287A (en) * 1996-08-29 1999-11-16 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6350456B1 (en) * 1997-03-13 2002-02-26 Corixa Corporation Compositions and methods for the prevention and treatment of M. tuberculosis infection

Also Published As

Publication number Publication date
TR200000113T2 (tr) 2000-05-22
WO1998053076A2 (en) 1998-11-26
AU7591698A (en) 1998-12-11
US20010012888A1 (en) 2001-08-09
US6555653B2 (en) 2003-04-29
IL133055A0 (en) 2001-03-19
CA2290754A1 (en) 1998-11-26
NO995690D0 (no) 1999-11-19
KR20010012813A (ko) 2001-02-26
PL337333A1 (en) 2000-08-14
BR9809443A (pt) 2000-06-13
WO1998053076A3 (en) 1999-04-01

Similar Documents

Publication Publication Date Title
NO995690L (no) Forbindelser for diagnose av tuberkulose og metoder for deres anvendelse
NO991693L (no) Forbindelser og metoder for diagnose av tuberkulose
MX9801687A (es) Compuestos y metodos para el diagnostico de tuberculosis.
DK1307564T3 (da) Forbindelser og fremgangsmåde til behandling og diagnose af chlamydiainfektion
NO20012812D0 (no) Forbindelser og fremgangsmåter for behandling og diagnose av chlamydiainfeksjon
WO2001062893A3 (en) Compounds and methods for diagnosis and immunotherapy of tuberculosis
BR0016066A (pt) Compostos e métodos para tratamento e diagnóstico de infecção clamidial
WO1998042740A3 (en) Compounds and methods for the diagnosis and treatment of ehrlichia infection
EP2192128A3 (en) Compounds and methods for treatment and diagnosis of chlamydial infection
EP1297147B8 (en) Compositions for the diagnosis and treatment of herpes simplex virus infection
EP1712629A3 (en) Compounds and methods for diagnosis of tuberculosis
TH84254A (th) สารประกอบและวิธีสำหรับการวินิจฉัยวัณโรค
TH84254B (th) สารประกอบและวิธีสำหรับการวินิจฉัยวัณโรค
AR013326A1 (es) POLIPEPTIDO AISLADO, MOLECULA DE ADN, VECTOR DE EXPRESION RECOMBINANTE, CELULA HUESPED, METODO PARa DETECTAR LA INFECCION DE M.TUBERCULOSIS EN UNAMUESTRA BIOLOGICA, EQUIPO PARA DIAGNOSTICO, ANTICUERPO MONOCLONAL, Y ANTICUERPO POLICLONAL, PROTEINAS DE FUSION

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application